MicroRNA 1913 (MIR1913)

MicroRNA 1913 (MIR1913, also known as hsa-mir-1913 and variants) is a small, non-coding RNA molecule classified as a microRNA. MicroRNAs (miRNAs) are short (typically 21–23 nucleotides), single-stranded RNA sequences that regulate gene expression at the post-transcriptional level, usually by binding to complementary sequences in target mRNAs and promoting either their degradation or translational inhibition[1][7]. The bulk of scientific knowledge describes general microRNA functions, which include cellular processes such as cell proliferation, differentiation, apoptosis, and various disease mechanisms, notably in cancer and as biomarkers[1][2][3][4]. MicroRNAs are not considered classic therapeutic targets like receptors, enzymes, or ion channels; they represent a distinct class of gene-regulatory molecules[1][7].\n\nThere is currently no evidence that MIR1913 is a well-established or actively pursued drug target, nor are there known drugs or clinical agents specifically acting on this microRNA. The published literature on \"microRNA-1913\" is extremely sparse or absent, indicating that it is not a validated molecular target in biomedicine, unlike well-studied miRNAs such as miR-124, miR-21, or miR-155[4][5]. The term likely refers to the gene encoding microRNA-1913, but not to a protein, receptor, enzyme, or classically druggable entity.\n\nMicroRNAs in general can function as biomarkers and play roles in disease pathogenesis and biology, but there is no documented individual functional or disease role for MIR1913 in peer-reviewed literature at this time[4].\n\nKey points regarding MIR1913:\n\n- It is not a canonical therapeutic target (such as a protein, enzyme, or receptor).\n- There is no evidence of drugs or therapies specifically interacting with MIR1913.\n- MIR1913 is a member of the general microRNA family of non-coding RNAs involved in post-transcriptional gene regulation[1][7].\n- The specificity and disease relevance of MIR1913 is unestablished.\n- The entry \"microRNA 1913\" is potentially incorrect as a target (not a validated or actionable drug target).\n\nSupporting general information is available for microRNAs as a class, but not for MIR1913 specifically[1][2][3][7]. If precise functional or disease associations are required for MIR1913, further experimental literature or database investigation would be necessary.

Other names

hsa-mir-1913MIRN1913MIR1913